Vannakambadi K Ganesh

Title: Vannakambadi K Ganesh: Innovator in Bacterial Infection Research

Introduction

Vannakambadi K Ganesh is a notable inventor based in Pearland, TX (US). He has made significant contributions to the field of bacterial infection research, holding a total of 3 patents. His work focuses on innovative methods to combat gram-positive bacterial infections.

Latest Patents

Ganesh's latest patents include groundbreaking inventions. One of his patents, titled "Targeting of ligand binding sites in ClfA," provides methods and compositions to reduce the binding of fibrinogen to ClfA in gram-positive bacterial infections. This invention utilizes monoclonal antibodies, polyclonal antibodies, and antigen-binding antibody fragments to specifically target portions of ClfA. Another significant patent is "Crystal structure of clumping factor A in complex with fibrinogen derived peptide and uses thereof." This patent discloses the crystal structure of ClfA in complex with fibrinogen-derived peptides, which can be utilized in designing ClfA-targeted vaccines and therapeutic agents, including monoclonal antibodies.

Career Highlights

Vannakambadi K Ganesh is affiliated with The Texas A&M University System, where he continues to advance research in his field. His innovative work has garnered attention and respect within the scientific community.

Collaborations

Ganesh has collaborated with esteemed colleagues, including Magnus A Hook and Ya-Ping Ko, to further enhance the impact of his research.

Conclusion

Vannakambadi K Ganesh is a prominent inventor whose work in bacterial infection research is paving the way for new therapeutic approaches. His patents reflect a commitment to innovation and a desire to improve health outcomes.